EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Burden of transfusion‐transmitted infections among patients with thalassaemia and sickle cell anaemia in India: A systematic review and meta‐analysis

Vaibhav Shandilya, Savitha Seetharaman, Sahana Parmeswaraiah Geetha, Divjot Singh Lamba, Soumya Das, Bijaya Kumar Padhi, Aravind P Gandhi

Transfusion Medicine · 2026-04 · 36 (2) · 121-132

DOI: 10.1111/tme.70044 ↗
AbstractBibliografische Angaben

Abstract

Abstract Lifelong blood transfusions, crucial for severe cases of thalassaemia and sickle cell disease (SCD), contribute to a high risk of transfusion‐transmitted infections (TTIs). The current systematic review and meta‐analysis determined the prevalence of transfusion‐transmitted infections (TTIs) among patients with thalassaemia and sickle cell anaemia in India. A systematic search was conducted in PubMed, Scopus, ProQuest, EMBASE and Web of Science for articles published up to September 13, 2025. Title abstract screening followed by full‐text review and data extraction was done by two independent reviewers. Risk of bias was assessed for the included studies. Meta‐analysis was conducted to estimate the pooled prevalence of TTIs. The systematic review and meta‐analysis identified 397 unique articles, with 39 selected for full‐text review. After exclusions, 24 studies spanning from 1990 to 2023 were included. All 24 studies included patients with beta thalassaemia, whereas only one study had data on sickle cell anaemia patients, so this review focuses mainly on the prevalence of TTI in patients with beta thalassaemia. The pooled prevalence of Hepatitis C was 22% (95% CI: 14%–30%; I 2 = 96%), Hepatitis B was 8% (95% CI: 2%–16%; I 2 = 96%) and HIV was 4% (95% CI: 2%–7%; I 2 = 77%) in beta‐thalassaemia patients, all showing high heterogeneity. Meta‐regression revealed a statistically significant decline over time in HBV (Beta = −0.0194, p =

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →